RayBiotech Providing Biomarker Services to Fox Chase Cancer Center | GenomeWeb

NEW YORK (GenomeWeb News) – RayBiotech announced on Tuesday a partnership to provide biomarker discovery and validation services to the Fox Chase Cancer Center.

The deal with the center's Genomics Core Facility also will provide RayBiotech's GMP-compliant and ISO 13485:2003-certified diagnostic discovery products to researchers throughout Fox Chase's campus. The services and products are based on RayBiotech's antibody array and ELISA product lines, the Norcross, Ga.-based firm said, adding Fox Chase is receiving preferred pricing as part of the deal.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.